Generex Biotechnology Corp (GNBTQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 07-2017 | 04-2017 | 01-2017 | 10-2016 | 07-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -76,833 | -64,446 | -15,223 | 560 | -3,223 |
| Depreciation Amortization | 13,385 | 14,484 | 14,336 | N/A | 265 |
| Accounts receivable | 1 | 1 | N/A | N/A | N/A |
| Other Working Capital | 994 | 686 | 232 | 208 | 1,100 |
| Other Operating Activity | 61,282 | 48,747 | 399 | -779 | 1,082 |
| Operating Cash Flow | $-1,170 | $-528 | $-256 | $-10 | $-776 |
| Cash Flows From Investing Activities | |||||
| Net Acquisitions | 12 | 12 | N/A | N/A | N/A |
| Purchase Of Investment | -4,000 | -4,000 | -500 | N/A | N/A |
| Sale Of Investment | 4,000 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 100 | 0 | 0 |
| Investing Cash Flow | $12 | $-3,988 | $-400 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 504 | N/A | N/A | N/A |
| Debt Issued | 1,675 | 982 | 656 | N/A | 50 |
| Debt Repayment | -689 | -14 | N/A | N/A | N/A |
| Common Stock Issued | 50 | 50 | 50 | N/A | 3 |
| Other Financing Activity | 3,000 | 3,000 | 0 | 0 | 0 |
| Financing Cash Flow | $4,036 | $4,522 | $706 | $N/A | $53 |
| Exchange Rate Effect | -16 | 14 | 9 | 0 | -11 |
| Beginning Cash Position | 17 | 17 | 17 | 17 | 750 |
| End Cash Position | 2,879 | 37 | 75 | 7 | 17 |
| Net Cash Flow | $2,862 | $20 | $58 | $-10 | $-733 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,170 | -528 | -256 | -10 | -776 |
| Free Cash Flow | -1,170 | -528 | -256 | -10 | -776 |